Literature DB >> 24229712

Incidence and prevalence of Toxoplasma gondii infection in women in France, 1980-2020: model-based estimation.

F Nogareda1, Y Le Strat1, I Villena2, H De Valk1, V Goulet1.   

Abstract

Toxoplasmosis is a worldwide zoonosis due to Toxoplasma gondii, a ubiquitous protozoan parasite of warm-blooded animals including humans. In pregnant women, primary infection can cause congenital toxoplasmosis resulting in severe malformations in the newborn. Since 1978, public health authorities in France have implemented a congenital toxoplasmosis prevention programme, including monthly serological screening of all seronegative pregnant women, and treatment in case of seroconversion. However, this programme does not produce systematic surveillance data on incidence and prevalence. Our objective was to estimate the incidence and prevalence of T. gondii infection, and the incidence of seroconversion during pregnancy in women in France. We used a catalytic model to estimate incidence and prevalence of Toxoplasma infection between 1980 and 2020 in women of childbearing age. We used age- and time-specific seroprevalence data obtained from the National Perinatal Surveys (NPS) conducted in 1995, 2003 and 2010. We assumed that incidence depends both on age and calendar time, and can be expressed as the product of two unknown functions. We also estimated incidence of seroconversion during pregnancy in 2010 from the NPS and the National Surveillance of Congenital Toxoplasmosis (ToxoSurv). We combined data of 42208 women aged 15-45 years with serology available from the three NPS. For women aged 30 years the modelled incidence decreased from 7·5/1000 susceptible women in 1980 to 3·5/1000 in 2000. In 2010 the incidence was 2·4/1000. The predicted incidence and prevalence for 2020 was 1·6/1000 and 27%, respectively. The incidence of seroconversion during pregnancy in 2010 was estimated at 2·1/1000 susceptible pregnant women (95% CI 1·3-3·1) from the NPS and 1·9 (95% CI 1·8-2·1) from ToxoSurv. Incidence and prevalence of Toxoplasma infection has decreased markedly during the last 30 years. This decrease may be explained by a lower exposure to the parasite by changes in food habits and by improved hygiene practices in meat production. Modelled estimations were consistent with estimates observed in other studies conducted previously in France. The catalytic modelling provides reliable estimates of incidence and prevalence of Toxoplasma infection over time. This approach might be useful for evaluating preventive programme for toxoplasmosis.

Entities:  

Mesh:

Year:  2013        PMID: 24229712      PMCID: PMC9151203          DOI: 10.1017/S0950268813002756

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  30 in total

1.  [Sero-epidemiologic profile of toxoplasmosis in northern Tunisia].

Authors:  A Bouratbine; E Siala; M K Chahed; K Aoun; R Ben Ismail
Journal:  Parasite       Date:  2001-03       Impact factor: 3.000

2.  Maternal and neonatal prevalence of toxoplasma and cytomegalovirus (CMV) antibodies and hepatitis-B antigens in an Egyptian rural area.

Authors:  A el-Nawawy; A T Soliman; O el Azzouni; M A Karim; S Demian; M el Sayed
Journal:  J Trop Pediatr       Date:  1996-06       Impact factor: 1.165

3.  Trends in perinatal health in France from 1995 to 2010. Results from the French National Perinatal Surveys.

Authors:  B Blondel; N Lelong; M Kermarrec; F Goffinet
Journal:  J Gynecol Obstet Biol Reprod (Paris)       Date:  2012-05-19

4.  Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling.

Authors:  D Dunn; M Wallon; F Peyron; E Petersen; C Peckham; R Gilbert
Journal:  Lancet       Date:  1999-05-29       Impact factor: 79.321

5.  Childhood hepatitis B virus infections in the United States before hepatitis B immunization.

Authors:  G L Armstrong; E E Mast; M Wojczynski; H S Margolis
Journal:  Pediatrics       Date:  2001-11       Impact factor: 7.124

6.  Toxoplasma gondii infection in the United States: seroprevalence and risk factors.

Authors:  J L Jones; D Kruszon-Moran; M Wilson; G McQuillan; T Navin; J B McAuley
Journal:  Am J Epidemiol       Date:  2001-08-15       Impact factor: 4.897

7.  Sero-epidemiological survey of Toxoplasma gondii infection in Ethiopia.

Authors:  M Guebre-Xabier; A Nurilign; A Gebre-Hiwot; A Hailu; Y Sissay; E Getachew; D Frommel
Journal:  Ethiop Med J       Date:  1993-07

Review 8.  Toxoplasmosis.

Authors:  J G Montoya; O Liesenfeld
Journal:  Lancet       Date:  2004-06-12       Impact factor: 79.321

9.  A simple model relevant to toxoplasmosis applied to epidemiologic results in France.

Authors:  L Papoz; F Simondon; W Saurin; H Sarmini
Journal:  Am J Epidemiol       Date:  1986-01       Impact factor: 4.897

10.  Incidence of cytomegalovirus infection among the general population and pregnant women in the United States.

Authors:  Fernando A B Colugnati; Stephanie A S Staras; Sheila C Dollard; Michael J Cannon
Journal:  BMC Infect Dis       Date:  2007-07-02       Impact factor: 3.090

View more
  24 in total

Review 1.  Use of Pathogen-Specific Antibody Biomarkers to Estimate Waterborne Infections in Population-Based Settings.

Authors:  Natalie G Exum; Nora Pisanic; Douglas A Granger; Kellogg J Schwab; Barbara Detrick; Margaret Kosek; Andrey I Egorov; Shannon M Griffin; Christopher D Heaney
Journal:  Curr Environ Health Rep       Date:  2016-09

Review 2.  Toxoplasma gondii: Biological Parameters of the Connection to Schizophrenia.

Authors:  Jianchun Xiao; Emese Prandovszky; Geetha Kannan; Mikhail V Pletnikov; Faith Dickerson; Emily G Severance; Robert H Yolken
Journal:  Schizophr Bull       Date:  2018-08-20       Impact factor: 9.306

3.  Evaluation of a New Immunochromatography Technology Test (LDBio Diagnostics) To Detect Toxoplasma IgG and IgM: Comparison with the Routine Architect Technique.

Authors:  Caroline Mahinc; Pierre Flori; Edouard Delaunay; Cécile Guillerme; Sana Charaoui; Hélène Raberin; Jamal Hafid; Coralie L'Ollivier
Journal:  J Clin Microbiol       Date:  2017-09-27       Impact factor: 5.948

4.  Help in the Choice of Automated or Semiautomated Immunoassays for Serological Diagnosis of Toxoplasmosis: Evaluation of Nine Immunoassays by the French National Reference Center for Toxoplasmosis.

Authors:  O Villard; B Cimon; C L'Ollivier; H Fricker-Hidalgo; N Godineau; S Houze; L Paris; H Pelloux; I Villena; E Candolfi
Journal:  J Clin Microbiol       Date:  2016-10-12       Impact factor: 5.948

5.  Seroepidemiology and risk factors of Toxoplasma gondii infection in undergraduate university female students in Jordan.

Authors:  M M Obaidat; N A Al-Sheyab; A E Bani Salman; S Q Lafi
Journal:  Epidemiol Infect       Date:  2014-12-29       Impact factor: 4.434

6.  Estimated Annual Numbers of Foodborne Pathogen-Associated Illnesses, Hospitalizations, and Deaths, France, 2008-2013.

Authors:  Dieter Van Cauteren; Yann Le Strat; Cécile Sommen; Mathias Bruyand; Mathieu Tourdjman; Nathalie Jourdan Da Silva; Elisabeth Couturier; Nelly Fournet; Henriette de Valk; Jean-Claude Desenclos
Journal:  Emerg Infect Dis       Date:  2017-09       Impact factor: 6.883

7.  Congenital Toxoplasmosis in France and the United States: One Parasite, Two Diverging Approaches.

Authors:  Francois Peyron; Rima Mc Leod; Daniel Ajzenberg; Despina Contopoulos-Ioannidis; François Kieffer; Laurent Mandelbrot; L David Sibley; Hervé Pelloux; Isabelle Villena; Martine Wallon; Jose G Montoya
Journal:  PLoS Negl Trop Dis       Date:  2017-02-16

Review 8.  Global initiative for congenital toxoplasmosis: an observational and international comparative clinical analysis.

Authors:  Kamal El Bissati; Pauline Levigne; Joseph Lykins; El Bachir Adlaoui; Amina Barkat; Amina Berraho; Majda Laboudi; Bouchra El Mansouri; Azeddine Ibrahimi; Mohamed Rhajaoui; Fred Quinn; Manoradhan Murugesan; Fouad Seghrouchni; Jorge Enrique Gómez-Marín; François Peyron; Rima McLeod
Journal:  Emerg Microbes Infect       Date:  2018-09-27       Impact factor: 7.163

9.  Prevalence, incidence estimations, and risk factors of Toxoplasma gondii infection in Germany: a representative, cross-sectional, serological study.

Authors:  Hendrik Wilking; Michael Thamm; Klaus Stark; Toni Aebischer; Frank Seeber
Journal:  Sci Rep       Date:  2016-03-03       Impact factor: 4.379

10.  Continuous Decline of Toxoplasma gondii Seroprevalence in Hospital: A 1997-2014 Longitudinal Study in Paris, France.

Authors:  Nicolas Guigue; Lucie Léon; Samia Hamane; Maud Gits-Muselli; Yann Le Strat; Alexandre Alanio; Stéphane Bretagne
Journal:  Front Microbiol       Date:  2018-10-05       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.